- 22.7k views
Tuberculosis Management
Tuberculosis (TB) management involves a comprehensive approach, from diagnosis to treatment, aimed at controlling and curing the infection. Early diagnosis is critical and is often done using sputum tests, chest X-rays, and molecular tests like GeneXpert. Once diagnosed, TB patients are typically treated with a standard regimen of first-line antibiotics, such as isoniazid, rifampicin, pyrazinamide, and ethambutol, over a course of six to nine months. Drug-resistant TB, particularly multidrug-resistant TB (MDR-TB), requires more complex treatment using second-line drugs for longer periods, often up to two years. Adherence to the treatment regimen is crucial, as incomplete treatment can lead to resistance.
About the Speaker
Dr. Deepak Muthreja
Head of Pulmonary Critical Care, American Oncology Institute, Nagpur
Dr. Deepak Muthreja, a highly skilled pulmonologist, completed his MBBS at Government Medical College, Nagpur, followed by an MD in TB and Chest Diseases at P.D.U. Medical College, Rajkot, and a DNB in Pulmonary Medicine. He also earned European Diplomas in Adult and Pediatric Respiratory Medicine from the University of Bern, Switzerland. With over 2,000 bronchoscopy procedures, 200 thoracoscopies, and the management of more than 10,000 respiratory disease cases, including 1,000 COVID-19 patients, Dr. Muthreja is an expert in both adult and pediatric respiratory care. He also excels in research, hospital operations, and training junior staff.
Upcoming Case Discussions
Gynaecologist’s Guide to Ovarian Cancer
Join us for a special webinar on World Ovarian Cancer Day, titled "Gynaecologist’s Guide to Ovarian Cancer." This expert-led session will delve into the latest advancements in early diagnosis, risk stratification, and evidence-based management of ovarian cancer. Tailored for gynecologists and healthcare professionals, the session will also explore real-world case discussions and multidisciplinary treatment approaches. Let’s come together to raise awareness and empower clinicians in the fight against this silent but deadly disease
Massive Transfusion Protocol
Massive Transfusion Protocol (MTP) is a standardized medical procedure activated in cases of severe hemorrhage, typically involving the rapid administration of large volumes of blood products. The goal is to restore circulating volume, maintain hemostasis, and prevent the lethal triad of hypothermia, acidosis, and coagulopathy. MTP usually involves a balanced ratio of packed red blood cells, plasma, and platelets, often in a 1:1:1 ratio. Early activation and coordination among trauma teams, laboratory services, and blood banks are essential for its success.
Clinical Approach In Case of CHD
A congenital heart defect diagnosis can be made either before or after the baby is born. Fetal ultrasonography, which is a common prenatal test, can reveal signs of some cardiac problems. A healthcare provider may suspect a congenital heart abnormality in a newborn if the child has: Growth pauses. Variations in nail, tongue, or lip color. Treatment procedures need to be followed either before or during the diagnosis-making process.
Fever Management in Pediatric Emergency
Fever management in pediatric emergencies involves prompt assessment to determine the underlying cause and severity. Accurate temperature measurement is essential for guiding treatment decisions. Antipyretics like acetaminophen or ibuprofen are commonly used to reduce fever and alleviate discomfort. Monitoring for signs of serious illness, such as meningitis or sepsis, is crucial for timely intervention. Educating caregivers on fever management and when to seek medical help ensures better outcomes for pediatric patients.
Latent Autoimmune Diabetes In Adults
Adult-onset autoimmune disease known as latent autoimmune diabetes of adults (LADA) does not require insulin for glycemic management during the first six months following diagnosis. Although LADA is frequently misdiagnosed as type 2 diabetes, it has genetic, immunologic, and metabolic characteristics with both types 1 and 2 diabetes mellitus (DM) (T2DM). Similar to type 2 diabetes, lifestyle modifications may halt the advancement of LADA, as the condition is caused by multiple unknown variables.
